Many individuals visit emergency rooms for severe hypoglycaemia, of which some will be hospitalized due to this safety concern. In this touchENDOCRINOLOGY interview, we speak with Dr Diana Isaacs (Endocrine Clinical Pharmacy Specialist, Cleveland Clinic, Cleveland, OH, USA) to discuss the classification and treatment options for hypoglycaemia, and clinical experience and evidence-based practices for the treatment and prevention of hypoglycaemia.
The abstract entitled: ‘Don’t Go Low! Clinical Strategies on Optimal Treatment and Prevention of Hypoglycemia‘ was presented at the Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, 12-15 Aug, 2022
- Could you give us an overview of the health burden of hypoglycaemia in diabetes? (0:15)
- How is hypoglycaemia classified? (0:42)
- What are the treatment options for hypoglycaemia? (1:17)
- Why is glucagon underutilized in cases of hyperglycaemia? (2:14)
- What changes are needed in routine clinical practice in the prevention and treatment of hypoglycaemia? (3:46)
Disclosures: Diana Isaacs is a consultant for Eli Lilly, and Sanofi; and is a speaker’s bureau participant for Dexcom, Abbott, Bayer, Insulet, Medtronic, Cequr, and Novo Nordisk.
Support: Interview supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Recorded as a highlight of ADCES 2022
Click here for more related content.
Share this Video
Related Videos In Diabetes
Chantal Mathieu: Research highlights from 2022
We were delighted to speak with our editorial board member Prof. Chantal Mathieu (University Hospital Gasthuisberg Leuven, Leuven, Belgium) around this year’s research highlights in diabetes and what to look out for in 2023. Questions What are the key clinical highlights from 2022 in the field of diabetes? (0:16) What are the hot topics and […]
José García-Tirado, DTM 2022: RocketAP in Practice: Results from Pilot and Feasibility Trials
In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) gives an overview of RocketAP and discusses how the RocketAP compares to the USS-Virginia system and also what the next steps in the clinical development of the Rocket AP will be. The abstract entitled: ‘RocketAP in Practice: Results from Pilot and Feasibility […]
José García-Tirado, DTM 2022: Challenges in the development of artificial pancreas systems
An artificial pancreas is a system made of three parts that work together to mimic how a healthy pancreas controls blood glucose in the body. In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) discusses the major challenges in the development of artificial pancreas systems. The abstract entitled: ‘RocketAP in Practice: Results from Pilot […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!